The molecular mechanisms underlying its osteogenic activity will be investigated by examining key signalling pathways, such as Wnt, BMP, and Runx2, to assess ginkgetin’s therapeutic potential for treating osteoporosis. The gene discussed is RUNX2; the disease is osteoporosis.